What was supposed to be a banner year for marijuana legalization is becoming a bust.
The latest official monthly sales data for recreational marijuana sales in Illinois have been published. Combined with the previous two months' data, they show that nearly $110 million worth of legal cannabis products were sold in the first quarter of 2020.
If COVID-19 has made anything clear, it’s the precarious position of many vital global supply chains. One of the most alarming issues is the risk to pharmaceutical production networks. Last month China’s manufacturing and production ground to a halt as the country went into lockdown to contain the virus. This shutdown had an immediate impact on industries around the world, including pharmaceutical ingredients.
Most cannabis stocks have been crushed during the stock market meltdown resulting from the coronavirus pandemic. But this major downturn presents opportunities to buy shares of the strongest players in the cannabis industry at discounted prices.
A preliminary study looking at the impact of COVID-19 on cannabis patients, led by the University of Miami, will be utilising epidemiology expertise, and looking at data collected on the patterns and trends of medical cannabis patients during the coronavirus outbreak.
Illinois’ new recreational marijuana market is off to a hot start even amid the spread of coronavirus. Earlier this week, the state announced nearly $36 million worth of legal cannabis was sold in March — on par with numbers from February.
The cannabis bankruptcy filings are starting to roll in.
Electronic devices have changed chemistry. Just as home kitchen counters now feature machines—such as electric kettles and multicookers—that make food preparation more convenient, so modern laboratory benches have dedicated labor-saving devices. For many labs, especially within organic chemistry, one of the most commonly seen and frequently used pieces of equipment is the rotary evaporator. Next-generation, electronic rotary evaporators are beginning to offer tangible and significant performance benefits.
Marijuana stocks had a rough 2019. The Horizons Marijuana Life Sciences ETF (OTC: HMLSF) fell 39% last year as the S&P 500 rose by 29%. The honeymoon stage for the cannabis industry is long over. And although the outbreak of the coronavirus isn't going to do the industry any favors this year, the reality is that marijuana stocks were going to face problems in 2020 either way.
America’s 243,000-strong legal cannabis workers are rapidly adopting local, state, federal and international health guidelines to keep working as essential businesses during the COVID-19 pandemic.
Regulators have de facto deputized marijuana dispensary operators coast to coast as frontline health care workers—doling out pain and anxiety medication, for starters.
